Publications by authors named "Haopeng Zhao"

Claim this Profile
S
Simultaneous determination of icotinib, osimertinib, aumolertinib, and anlotinib in human plasma for therapeutic drug monitoring by UPLC-MS/MS.
Yuxiang Xu, Hongxin Qie, Haopeng Zhao, Xiaonan Gao, Jinglin Gao

J Pharm Biomed Anal· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of furmonertinib in human plasma and cerebrospinal fluid by UPLC-MS/MS: Application in lung cancer patients with and without brain metastasis.
Hongxin Qie, Cong Song, Yuxiang Xu, Haopeng Zhao, Wenlin Gong

J Chromatogr B Analyt Technol Biomed Life Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pharmacokinetics and relative bioavailability of pentoxifylline and its metabolite in beagle dogs following different formulations.
Yuxiang Xu, Hongxin Qie, Haopeng Zhao, Wenlin Gong, Peiyuan Wang

Front Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A validated UPLC-MS/MS method for quantification of pyrotinib and population pharmacokinetic study of pyrotinib in HER2-positive breast cancer patients.
Yunfang Zhu, Yuxiang Xu, Haopeng Zhao, Hongxin Qie, Xiaonan Gao

Front Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation a UPLC-MS/MS Method for Quantification of Pentoxifylline in Beagle Plasma: Application for Pharmacokinetic Study of Food Effect.
Yuxiang Xu, Xiaonan Gao, Yunfang Zhu, Qi Zhang, Hongxin Qie, Haopeng Zhao

Drug Des Devel Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis